The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2015

Filed:

Dec. 15, 2009
Applicants:

Robert J. Levy, Merion Station, PA (US);

Michael Chorny, Huntingdon Valley, PA (US);

Vladimir Muzykantov, Warwick, PA (US);

Elizabeth Hood, Philadelphia, PA (US);

Inventors:

Robert J. Levy, Merion Station, PA (US);

Michael Chorny, Huntingdon Valley, PA (US);

Vladimir Muzykantov, Warwick, PA (US);

Elizabeth Hood, Philadelphia, PA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/44 (2006.01); A61N 2/10 (2006.01); A61M 31/00 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 47/42 (2006.01); A61K 47/48 (2006.01); A61K 48/00 (2006.01); A61L 31/16 (2006.01); C12N 15/11 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5094 (2013.01); A61K 9/5115 (2013.01); A61K 9/5123 (2013.01); A61K 9/5146 (2013.01); A61K 9/5153 (2013.01); A61K 9/5169 (2013.01); A61K 9/5192 (2013.01); A61K 47/42 (2013.01); A61K 47/48315 (2013.01); A61K 47/48561 (2013.01); A61K 47/48853 (2013.01); A61K 47/48915 (2013.01); A61K 48/0008 (2013.01); A61K 48/0041 (2013.01); A61K 48/0083 (2013.01); A61L 31/16 (2013.01); C12N 15/111 (2013.01); C12N 15/86 (2013.01); A61K 47/48192 (2013.01); A61K 47/48323 (2013.01); A61L 2300/416 (2013.01); A61L 2300/60 (2013.01); A61L 2300/624 (2013.01); C12N 2320/32 (2013.01); C12N 2710/10343 (2013.01);
Abstract

Systems and methods for magnetic targeting of therapeutic particles are provided. Therapeutic particles comprise one or more magnetic or magnetizable materials and at least one therapeutic agent. Therapeutic particles are specifically targeted using uniform magnetic fields capable of magnetizing magnetizable materials, and can be targeted to particular locations in the body, or can be targeted for capture, containment, and removal. Therapeutic particles can comprise antioxidant enzymes, and can be targeted to cells to protect the cells from oxidative damage.


Find Patent Forward Citations

Loading…